August 2007
ICIS Chemical Business;8/20/2007, Vol. 272 Issue 7, p24
Trade Publication
The article reports on several issues related to the chemical industry. U.S. President George W. Bush presented the National Medal of Technology award for technological achievement to U.S.-based pharmaceutical firm Wyeth Inc., which developed Prevnar, a vaccine against invasive neumococcal disease in children. The United Nations Food and Agriculture Organization will hold a top-level meeting to frame international rules for the biofuel market in June 2008.


Related Articles

  • MARKET BRIEFS.  // Chemical Market Reporter;3/26/2001, Vol. 259 Issue 13, p10 

    Provides market updates on the chemical industry in the United States as of March 2001. Details on the nutritional oil utilized by Wyeth Nutritionals International; Estimated prices of benzene, ethylene oxide and methanol.

  • Rotavirus vaccine withdrawn. Maudlin, Robert K. // Modern Medicine;Dec99, Vol. 67 Issue 12, p55 

    Reports on the withdrawal of RotaShield rotavirus vaccine by Wyeth Lederle Vaccines company from the market because of the drug's possible association with the development of intussusception. Postponement of the drug's administration.

  • Prevnar 13 approved.  // Monthly Prescribing Reference;Mar2010, Vol. 26 Issue 3, pA19 

    The article reports on the approval of Prevnar 13, a pneumococcal 13-valent conjugate vaccine from Wyeth, for the prevention of invasive pneumococcal disease and otitis media in children aged six weeks to five years.

  • Wyeth Recalls One Lot of Prevnar.  // BioPharm International;Aug2009, Vol. 22 Issue 8, p15 

    The article reports on the decision of Wyeth to recall a lot of single-dose prefilled syringes of Prevnar, the company's pneumococcall 7-valent conjugate vaccine, in the U.S. The company determined that a portion of a bulk lot of prefilled syringes not intended for sale was inadvertently...

  • FluMist Is Latest Entry in Vaccine Market.  // Chemical Market Reporter;6/30/2003, Vol. 263 Issue 26, p7 

    Reports on the introduction of FluMist, an influenza vaccine delivered as a nasal mist. MedImmune Inc. and Wyeth's development of the product; Estimated sales of FluMist in 2003.

  • NEWS IN BRIEF. Cozier, Muriel // European Chemical News;10/18/2004, Vol. 81 Issue 2120, p42 

    Presents news briefs on the chemical industry in Europe as of October 18, 2004. Winner in the ABB Environment Award category of the IChemE's awards scheme in London, England; Caution issued by the Food and Agriculture Organisation of the United Nations regarding the threat posed by toxic wastes...

  • Regulatory & Healthcare News.  // PharmacoEconomics & Outcomes News;4/18/2009, Issue 576, p13 

    This section presents regulatory and health care updates. A briefing paper revealed the life-saving benefits of rotavirus vaccines. Saudi Arabia has added Wyeth's pneumococcal 7-valent CRM19 vaccine to its national immunization programme (NIP). Abbott Laboratories reduced the price of its...

  • The American Academy of Family Physicians Foundation Announces 2008 AAFP/F Wyeth Immunization Award Winners.  // New York Family Medicine News;Sep2008, p4 

    The article announces the 2008 American Academy of Family Physicians Foundation (AAFP/F) Wyeth Inc. Immunization Award which recognizes the family medicine residency programs that help ensure children's welfare and protection through increased childhood immunization rates. The winning programs...

  • Prevnar case study.  // Prevnar: the First Vaccine Blockbuster;Jan2008, p1 

    • The clinical impact of Prevnar on the incidence of invasive pneumococcal disease in the US was enormous. Before the launch of the vaccine, the overall incidence of invasive pneumococcal in the US was estimated to be approximately 188 cases per 100,000 young children aged less than 2...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics